DE69934113D1 - Antiangiogene substanz zur behandlung von krebs, arthritis und netzhauterkrankungen - Google Patents

Antiangiogene substanz zur behandlung von krebs, arthritis und netzhauterkrankungen

Info

Publication number
DE69934113D1
DE69934113D1 DE69934113T DE69934113T DE69934113D1 DE 69934113 D1 DE69934113 D1 DE 69934113D1 DE 69934113 T DE69934113 T DE 69934113T DE 69934113 T DE69934113 T DE 69934113T DE 69934113 D1 DE69934113 D1 DE 69934113D1
Authority
DE
Germany
Prior art keywords
arthritis
cancer
network
treatment
gland diseases
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
DE69934113T
Other languages
English (en)
Other versions
DE69934113T2 (de
Inventor
Megumi Kawai
Jack Henkin
S Sheppard
A Craig
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Publication of DE69934113D1 publication Critical patent/DE69934113D1/de
Application granted granted Critical
Publication of DE69934113T2 publication Critical patent/DE69934113T2/de
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C237/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups
    • C07C237/02—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton
    • C07C237/22—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by amino groups having the carbon atoms of the carboxamide groups bound to acyclic carbon atoms of the carbon skeleton having nitrogen atoms of amino groups bound to the carbon skeleton of the acid part, further acylated
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C311/00—Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/30—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups
    • C07C311/45—Sulfonamides, the carbon skeleton of the acid part being further substituted by singly-bound nitrogen atoms, not being part of nitro or nitroso groups at least one of the singly-bound nitrogen atoms being part of any of the groups, X being a hetero atom, Y being any atom, e.g. N-acylaminosulfonamides
    • C07C311/46—Y being a hydrogen or a carbon atom

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pyridine Compounds (AREA)
  • Steroid Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
DE69934113T 1998-05-22 1999-05-21 Antiangiogene substanz zur behandlung von krebs, arthritis und netzhauterkrankungen Expired - Lifetime DE69934113T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US84063 1987-08-11
US8406398A 1998-05-22 1998-05-22
PCT/US1999/011309 WO1999061406A2 (en) 1998-05-22 1999-05-21 Antiangiogenic drug to treat cancer, arthritis and retinopathy

Publications (2)

Publication Number Publication Date
DE69934113D1 true DE69934113D1 (de) 2007-01-04
DE69934113T2 DE69934113T2 (de) 2007-06-06

Family

ID=22182661

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69934113T Expired - Lifetime DE69934113T2 (de) 1998-05-22 1999-05-21 Antiangiogene substanz zur behandlung von krebs, arthritis und netzhauterkrankungen

Country Status (10)

Country Link
EP (1) EP1080070B1 (de)
JP (1) JP4554816B2 (de)
AT (1) ATE346036T1 (de)
CA (1) CA2332535C (de)
CY (1) CY1105977T1 (de)
DE (1) DE69934113T2 (de)
DK (1) DK1080070T3 (de)
ES (1) ES2276519T3 (de)
PT (1) PT1080070E (de)
WO (1) WO1999061406A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6632961B1 (en) 1998-05-22 2003-10-14 Abbott Laboratories Antiangiogenic drug to treat cancer, arthritis and retinopathy
US20030187026A1 (en) 2001-12-13 2003-10-02 Qun Li Kinase inhibitors
AU2002353147A1 (en) * 2001-12-13 2003-06-30 Abbott Laboratories 3-(phenyl-alkoxy)-5-(phenyl)-pyridine derivatives and related compounds as kinase inhibitors for the treatment of cancer
WO2005035524A1 (en) * 2003-10-09 2005-04-21 Abbott Laboratories Pyrrolidinyl urea derivatives as angiogensis inhibitors
US7592466B2 (en) 2003-10-09 2009-09-22 Abbott Laboratories Ureas having antiangiogenic activity
CA2594411C (en) 2005-01-13 2013-05-21 University Of Wollongong Peptidic biaryl antibacterial compounds comprising one or more basic amino acids

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US1922205A (en) * 1932-01-26 1933-08-15 Squibb & Sons Inc 2-carboxy-5-amino diphenyl
GB1498996A (en) * 1975-10-09 1978-01-25 Hidaka H Omega-aminoalkanoic acid arylamides
IT1050750B (it) * 1975-12-05 1981-03-20 Erba Carlo Spa Derivati della 3.4 di idro chinazolina
US4147802A (en) * 1978-03-17 1979-04-03 Stanley Drug Products, Inc. Method of treating bacterial infections
EP0183271B1 (de) * 1984-11-30 1990-05-16 Shosuke Okamoto Lysinderivat und Proteinase-Inhibitor
US5238652A (en) * 1990-06-20 1993-08-24 Drug Screening Systems, Inc. Analytical test devices for competition assay for drugs of non-protein antigens using immunochromatographic techniques
GB9200415D0 (en) * 1992-01-09 1992-02-26 Bagshawe Kenneth D Inactivation of cytotoxic drugs
ZA935617B (en) * 1992-08-14 1994-03-07 Akzo Nv Antiprogestogen containing contraceptives.

Also Published As

Publication number Publication date
PT1080070E (pt) 2007-02-28
CY1105977T1 (el) 2011-04-06
ATE346036T1 (de) 2006-12-15
CA2332535A1 (en) 1999-12-02
DE69934113T2 (de) 2007-06-06
DK1080070T3 (da) 2007-02-26
ES2276519T3 (es) 2007-06-16
EP1080070A2 (de) 2001-03-07
EP1080070B1 (de) 2006-11-22
WO1999061406A2 (en) 1999-12-02
WO1999061406A3 (en) 2000-01-27
JP4554816B2 (ja) 2010-09-29
JP2002516303A (ja) 2002-06-04
CA2332535C (en) 2006-02-28

Similar Documents

Publication Publication Date Title
NO20003018D0 (no) Triazinangiogenese-inhibitorer
ATE309237T1 (de) Aromatische heterozyklische verbindungen als antientzündungwirkstoffe
MXPA03011484A (es) Heteroarilos multiciclicos sustituidos con quinuclidinas para el tratamiento de enfermedades.
BR0008922A (pt) Compostos úteis como agentes antiinflamatórios
MY138252A (en) Azabicyclic-substitud fused-heteroaryl compounds for the treatment of disease
BR0015911A (pt) Derivados de benzoimidazole úteis como agentes antiproliferativos
MY141661A (en) 17b-hydroxysteroid dehydrogenase type 3 inhibitors for the treatment of androgen dependent diseases
DE69716810D1 (de) 2,3-Disubstituierte-(5,6)-heteroarylkondensierte-pyrimidin-4-one
DK1315506T3 (da) Phospholipidderivater af valproinsyre og blandinger deraf
ATE238981T1 (de) Antitumorwirkstoffe
RU94036745A (ru) Производные галантамина и фармацевтическая композиция
DE60102171D1 (de) Ketolidantibiotika
DE69933885D1 (de) Triphenylbutenderivate zur behandlung von neurologischen störungen
DE69934113D1 (de) Antiangiogene substanz zur behandlung von krebs, arthritis und netzhauterkrankungen
DE69917005D1 (de) Substituierte pyrrolobenzimidazolderivate zur entzündungshemmung
MXPA04000805A (es) Peptidos que tienen actividad antiangiogenica.
TW200730177A (en) 4 anilino-3-quinolinecarbonitriles for the treatment of cancer
NO20032411D0 (no) Anvendelse av substituerte 6-dimetylaminometyl-1-fenyl- cykloheksan-forbindelser for behandling av urininkontinens
DK1212315T3 (da) Nye chalconer
ATE271384T1 (de) Arylnitron therapeutische mittel zur behandlung von entzündlichen darmerkrankungen
DE60219680D1 (de) Amin-1,2- und -1,3-diolverbindungen und deren verwendung zur behandlung von alzheimer-krankheit
ATE263556T1 (de) Phenylessigsäure enthaltende zusammensetzungen zur behandlung und vorbeugung der atherosklerose und der restenose
ATE327240T1 (de) 2ß OXO-VORUSCHARIN UND DERIVATEN

Legal Events

Date Code Title Description
8364 No opposition during term of opposition